These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 17254959)

  • 1. Oncogene-induced senescence pathways weave an intricate tapestry.
    Yaswen P; Campisi J
    Cell; 2007 Jan; 128(2):233-4. PubMed ID: 17254959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRAK is essential for ras-induced senescence and tumor suppression.
    Sun P; Yoshizuka N; New L; Moser BA; Li Y; Liao R; Xie C; Chen J; Deng Q; Yamout M; Dong MQ; Frangou CG; Yates JR; Wright PE; Han J
    Cell; 2007 Jan; 128(2):295-308. PubMed ID: 17254968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A posttranslational modification cascade involving p38, Tip60, and PRAK mediates oncogene-induced senescence.
    Zheng H; Seit-Nebi A; Han X; Aslanian A; Tat J; Liao R; Yates JR; Sun P
    Mol Cell; 2013 Jun; 50(5):699-710. PubMed ID: 23685072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.
    Serrano M; Lin AW; McCurrach ME; Beach D; Lowe SW
    Cell; 1997 Mar; 88(5):593-602. PubMed ID: 9054499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence.
    Mallette FA; Gaumont-Leclerc MF; Ferbeyre G
    Genes Dev; 2007 Jan; 21(1):43-8. PubMed ID: 17210786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage.
    Townsend PA; Cragg MS; Davidson SM; McCormick J; Barry S; Lawrence KM; Knight RA; Hubank M; Chen PL; Latchman DS; Stephanou A
    J Cell Sci; 2005 Apr; 118(Pt 8):1629-39. PubMed ID: 15784679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence.
    Barnoud T; Schmidt ML; Donninger H; Clark GJ
    Cancer Lett; 2017 Aug; 400():30-36. PubMed ID: 28455242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide metabolism, oncogene-induced senescence and cancer.
    Aird KM; Zhang R
    Cancer Lett; 2015 Jan; 356(2 Pt A):204-10. PubMed ID: 24486217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogene-induced senescence: a double edged sword in cancer.
    Liu XL; Ding J; Meng LH
    Acta Pharmacol Sin; 2018 Oct; 39(10):1553-1558. PubMed ID: 29620049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ing1 mediates p53 accumulation and chromatin modification in response to oncogenic stress.
    Abad M; Menéndez C; Füchtbauer A; Serrano M; Füchtbauer EM; Palmero I
    J Biol Chem; 2007 Oct; 282(42):31060-7. PubMed ID: 17693408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
    Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
    J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
    Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNAJB9 Inhibits p53-Dependent Oncogene-Induced Senescence and Induces Cell Transformation.
    Lee HJ; Jung YJ; Lee S; Kim JI; Han JA
    Mol Cells; 2020 Apr; 43(4):397-407. PubMed ID: 32264658
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of a DNA Damage-Induced Alternative Splicing Pathway That Regulates p53 and Cellular Senescence Markers.
    Chen J; Crutchley J; Zhang D; Owzar K; Kastan MB
    Cancer Discov; 2017 Jul; 7(7):766-781. PubMed ID: 28288992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of p53 by oncogenes.
    Lowe SW
    Endocr Relat Cancer; 1999 Mar; 6(1):45-8. PubMed ID: 10732786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of the LXCXE binding cleft of pRb facilitates transformation by ras in vitro but does not promote tumorigenesis in vivo.
    Talluri S; Francis SM; Dick FA
    PLoS One; 2013; 8(8):e72236. PubMed ID: 23936539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmented cancer resistance and DNA damage response phenotypes in PPM1D null mice.
    Nannenga B; Lu X; Dumble M; Van Maanen M; Nguyen TA; Sutton R; Kumar TR; Donehower LA
    Mol Carcinog; 2006 Aug; 45(8):594-604. PubMed ID: 16652371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NORE1A is a Ras senescence effector that controls the apoptotic/senescent balance of p53 via HIPK2.
    Donninger H; Calvisi DF; Barnoud T; Clark J; Schmidt ML; Vos MD; Clark GJ
    J Cell Biol; 2015 Mar; 208(6):777-89. PubMed ID: 25778922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new p53 target gene, RKIP, is essential for DNA damage-induced cellular senescence and suppression of ERK activation.
    Lee SJ; Lee SH; Yoon MH; Park BJ
    Neoplasia; 2013 Jul; 15(7):727-37. PubMed ID: 23814485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p38alpha and p38gamma mediate oncogenic ras-induced senescence through differential mechanisms.
    Kwong J; Hong L; Liao R; Deng Q; Han J; Sun P
    J Biol Chem; 2009 Apr; 284(17):11237-46. PubMed ID: 19251701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.